Printer Friendly
The Free Library
19,595,263 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Antigenics to Report Results on May 5, 2005; Conference Call to Follow.


NEW YORK New York, state, United States
New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of
 -- Antigenics Inc. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
: AGEN) will release its first quarter financial results before the market opens on May 5, 2005.

Antigenics executives will host a conference call at 11:00 a.m. ET that same day. To access the live call, dial 888.271.9082 (domestic) or 706.679.7741 (international); the access code is 5671279. The call will also be webcast and will be accessible from the company's website at www.antigenics.com/webcast/. A replay will be available approximately two hours after the call through midnight ET on May 12, 2005. The replay number is 800.642.1687 (domestic) or 706.645.9291 (international), and the access code is 5671279. The replay will also be available on the company's website approximately two hours after the live call.

Antigenics is working to develop personalized immunotherapeutics and revolutionary treatments for cancers and infectious diseases. The company's lead product candidate is Oncophage(R) (HSPPC-96), a late-stage, personalized cancer vaccine being evaluated in several indications, including renal cell carcinoma renal cell carcinoma
 or hypernephroma

Malignant tumour of the cells that cover and line the kidney. It usually affects persons over age 50 who have vascular disorders of the kidneys. It seldom causes pain, unless it is advanced.
 and metastatic Metastatic
The term used to describe a secondary cancer, or one that has spread from one area of the body to another.

Mentioned in: Coagulation Disorders


metastatic

pertaining to or of the nature of a metastasis.
 melanoma. Antigenics' portfolio of investigational products also includes AG-858 (HSPPC-70), a personalized cancer vaccine in Phase 2 development; two Phase 2 liposomal cancer treatments, Aroplatin(TM) and ATRA-IV; and AG-702/AG-707, a Phase 1 genital herpes Genital Herpes Definition

Genital herpes is a sexually transmitted disease caused by a herpes virus. The disease is characterized by the formation of fluid-filled, painful blisters in the genital area.
 program. For more information, please visit www.antigenics.com.
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Apr 28, 2005
Words:215
Previous Article:Zacks Buy List Highlights: Lone Star Technologies, Inc., Unit Corporation, Automatic Data Processing, Inc. and Ixia.
Next Article:Regal Entertainment Group Reports Results for the Fiscal First Quarter of 2005, Announces Pending Acquisition of Eastern Federal Theatres and...



Related Articles
Antigenics Announces Partial Clinical Hold on Phase III Trials for Kidney Cancer and Melanoma.
Antigenics Reports First Quarter 2004 Financial Results and Recent Highlights.
Antigenics Reports Third Quarter 2004 Financial Results and Recent Highlights.
Antigenics Reports Fourth Quarter and Year-End 2004 Financial Results and Highlights.
Antigenics Reports First Quarter 2005 Financial Results and Recent Highlights.
Antigenics Reports Second Quarter 2005 Financial Results and Recent Highlights and Pipeline Update.
Antigenics Reports Third Quarter 2005 Financial Results and Recent Highlights.
Antigenics Reports First Quarter 2006 Financial Results.
Antigenics Reports Third Quarter 2006 Financial Results.
Antigenics Reports Fourth Quarter and Year-End 2006 Financial Results.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles